These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
710 related articles for article (PubMed ID: 17156630)
21. Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis. Soós L; Szekanecz Z; Szabó Z; Fekete A; Zeher M; Horváth IF; Dankó K; Kapitány A; Végvári A; Sipka S; Szegedi G; Lakos G J Rheumatol; 2007 Aug; 34(8):1658-63. PubMed ID: 17611988 [TBL] [Abstract][Full Text] [Related]
22. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection. Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846 [TBL] [Abstract][Full Text] [Related]
23. High anti-collagen type-II antibody levels and induction of proinflammatory cytokines by anti-collagen antibody-containing immune complexes in vitro characterise a distinct rheumatoid arthritis phenotype associated with acute inflammation at the time of disease onset. Mullazehi M; Mathsson L; Lampa J; Rönnelid J Ann Rheum Dis; 2007 Apr; 66(4):537-41. PubMed ID: 17040962 [TBL] [Abstract][Full Text] [Related]
24. [Anti-cyclic citrullinated peptide antibodies as a diagnostic test for rheumatoid arthritis]. Orbach H; Shoenfeld Y Harefuah; 2003 Mar; 142(3):182-5, 239. PubMed ID: 12696470 [TBL] [Abstract][Full Text] [Related]
25. Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse. Burkhardt H; Koller T; Engström A; Nandakumar KS; Turnay J; Kraetsch HG; Kalden JR; Holmdahl R Arthritis Rheum; 2002 Sep; 46(9):2339-48. PubMed ID: 12355481 [TBL] [Abstract][Full Text] [Related]
26. Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis. Kapitány A; Szabó Z; Lakos G; Aleksza M; Végvári A; Soós L; Karányi Z; Sipka S; Szegedi G; Szekanecz Z Isr Med Assoc J; 2008 Jan; 10(1):32-6. PubMed ID: 18300568 [TBL] [Abstract][Full Text] [Related]
27. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis. van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872 [TBL] [Abstract][Full Text] [Related]
28. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis. Liu X; Jia R; Zhao J; Li Z J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936 [TBL] [Abstract][Full Text] [Related]
29. The detecting and clinical value of anti-cyclic citrullinated peptide antibodies in patients with systemic lupus erythematosus. Qing YF; Zhang QB; Zhou JG; Yuan GH; Wei J; Xing Y; Liu JP; Jiang L; Chen JP Lupus; 2009 Jul; 18(8):713-7. PubMed ID: 19502267 [TBL] [Abstract][Full Text] [Related]
30. Antibodies binding to citrullinated telopeptides of type I and type II collagens and to mutated citrullinated vimentin synergistically predict the development of seropositive rheumatoid arthritis. Koivula MK; Heliövaara M; Rissanen H; Palosuo T; Knekt P; Immonen H; Risteli J Ann Rheum Dis; 2012 Oct; 71(10):1666-70. PubMed ID: 22419777 [TBL] [Abstract][Full Text] [Related]
31. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Nielen MM; van Schaardenburg D; Reesink HW; van de Stadt RJ; van der Horst-Bruinsma IE; de Koning MH; Habibuw MR; Vandenbroucke JP; Dijkmans BA Arthritis Rheum; 2004 Feb; 50(2):380-6. PubMed ID: 14872479 [TBL] [Abstract][Full Text] [Related]
32. Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis. Bang H; Egerer K; Gauliard A; Lüthke K; Rudolph PE; Fredenhagen G; Berg W; Feist E; Burmester GR Arthritis Rheum; 2007 Aug; 56(8):2503-11. PubMed ID: 17665451 [TBL] [Abstract][Full Text] [Related]
33. Prevalence and significance of antibodies to citrullinated human papilloma virus-47 E2345-362 in rheumatoid arthritis. Shi J; Sun X; Zhao Y; Zhao J; Li Z J Autoimmun; 2008 Sep; 31(2):131-5. PubMed ID: 18511237 [TBL] [Abstract][Full Text] [Related]
34. Anti-cyclic citrullinated peptide antibodies are not associated with familial Mediterranean fever. Karatay S; Yildirim K; Erdal A; Uzkeser H; Erdem FH; Yanmaz V J Back Musculoskelet Rehabil; 2010; 23(1):21-3. PubMed ID: 20231785 [TBL] [Abstract][Full Text] [Related]
35. Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement. Alessandri C; Bombardieri M; Papa N; Cinquini M; Magrini L; Tincani A; Valesini G Ann Rheum Dis; 2004 Oct; 63(10):1218-21. PubMed ID: 15361374 [TBL] [Abstract][Full Text] [Related]
36. Uncoupling of collagen II metabolism in newly diagnosed, untreated rheumatoid arthritis is linked to inflammation and antibodies against cyclic citrullinated peptides. Christensen AF; Hørslev-Petersen K; Christgau S; Lindegaard HM; Lottenburger T; Junker K; Hetland ML; Stengaard-Pedersen K; Jacobsen S; Ellingsen T; Andersen LS; Hansen I; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen AJ; Tarp U; Pødenphant J; Heegaard NH; Vestergaard A; Jurik AG; Ostergaard M; Junker P J Rheumatol; 2010 Jun; 37(6):1113-20. PubMed ID: 20436079 [TBL] [Abstract][Full Text] [Related]
38. [Comparison and relevance of rheumatoid factors, antikeratin antibodies and anti-cyclic citrullinated peptides antibodies in rheumatoid arthritis]. Galati S; Beauvillain C; Renier G; Jeannin P; Masson C; Chevailler A Ann Biol Clin (Paris); 2008; 66(2):157-64. PubMed ID: 18390426 [TBL] [Abstract][Full Text] [Related]
39. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis. Charni N; Juillet F; Garnero P Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703 [TBL] [Abstract][Full Text] [Related]
40. Citrullinated fibrinogen detected as a soluble citrullinated autoantigen in rheumatoid arthritis synovial fluids. Takizawa Y; Suzuki A; Sawada T; Ohsaka M; Inoue T; Yamada R; Yamamoto K Ann Rheum Dis; 2006 Aug; 65(8):1013-20. PubMed ID: 16449316 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]